Diabetes is a life-long condition causing blood sugar levels to become too high. Whilst the condition cannot be cured, it can be controlled and monitored. A variety of assays have been developed for the diagnosis and monitoring of diabetes. Some of the diabetes reagents we have on offer include: Fructosamine, Glucose and HbA1c. In addition, there are a variety of Randox diabetes reagents for monitoring associated complications of diabetes including: Albumin, Beta-2 Microglobulin, Cystatin C, D-3-Hydroxybutyrate, Microalbumin and Non-Esterified Fatty Acids (NEFA).
To discover more about our range of diabetes reagents, select an option from the drop-down menu. Alternatively, read on to learn more about diabetes, its effects and the relevance of Randox diabetes reagents.
More information on diabetes diagnostics
7 million people worldwide are diagnosed with diabetes each year…
Diabetes is a chronic disease which causes an elevation of sugar levels within the blood. It occurs when the pancreas does not produce enough insulin, or when the body cannot effectively use the insulin it produces. This is because insulin regulates how the body uses and stores glucose and fat. It is a vital part of metabolism which is necessary for turning glucose into energy, and is required to remove the harmful, excess glucose from the blood. Without a sufficient amount of insulin, the body cannot use the glucose as fuel resulting in a buildup of glucose in the blood.
There are three types of diabetes, type 1, type 2 and gestational:
Type 1 diabetes manifests in childhood and is caused by deficiency (inherited or acquired) in the production of insulin by the pancreas and so the daily monitoring and administration of insulin is required.
Type 2 diabetes manifests later in life and occurs when the body produces insulin but does not use it effectively (known as insulin resistance). It is more common than type 1 diabetes, and is usually caused as a result of excess body fat and lack of physical activity.
Type 2 diabetes can occur in any individual regardless of weight. Excess abdominal visceral fat has also been correlated with increased risk of type 2 diabetes. Visceral fat is the fat that surrounds the vital organs in our bodies. High levels of visceral fat is common on those who have a high BMI, however those with a healthy BMI but do not eat a healthy diet or exercise also can have high levels of visceral fat. Additionally, heart disease, hypertension, stroke and some cancers has also been linked to type 2 diabetes.
If you are worried about your abdominal visceral fat levels ask your doctor for the Adiponectin test!
Gestational diabetes is the development of diabetes during pregnancy as a result of the body being unable to produce enough insulin to meet the extra needs during pregnancy. Gestational diabetes can cause problems for both the mother and baby during and after birth, however, it is possible to reduce the chances of these risks occurring if gestational diabetes is diagnosed and consistently monitored.
The risk of gestational diabetes is higher if the woman’s BMI is over 30, if the woman or woman’s mother or siblings have previously had gestational diabetes during pregnancy, or if the woman has previously given birth to a baby weighing 10lbs or more. Gestational diabetes can have serious effects on pregnancy including: polyhydramnios, pre-eclampsia, the baby developing jaundice or low blood sugar levels after birth, or stillbirth. Gestational diabetes can leave the woman susceptible to type 2 diabetes in the future.
A few signs and symptoms of diabetes…
Signs and symptoms of diabetes include unexplained weight loss, frequent urination, tiredness and lack of energy, excessive thirst, blurred vision, tingling sensation/numbness in the hands or feet and slow-healing wounds.
Ask your doctor to check your blood sugar levels!
If you are worried about your blood sugar levels ask for these simple tests which are used in the diagnosis and monitoring of diabetes…
- Glucose is a major source of energy for most cells in the body and obtained through carbohydrate enriched foods. Insulin helps control blood glucose levels to ensure they do not get too high, and as such, high levels of glucose in the blood is an indicator of diabetes
- HbA1c is used to identify the average amount of glucose in the blood over a 2-3-month period. It is a good indicator of diabetes, as well as enabling diabetic patients to understand how well their diabetes is being controlled
- Fructosamine is used in the monitoring of diabetes and is particularly useful in reviewing the effectiveness of medication adjustments. This is because it enables average glucose levels to be obtained over a 2-3 week period. In addition, it is used to monitor glucose levels of pregnant woman suffering from gestational diabetes which allows for the monitoring of both, mother and baby glucose levels. This is crucial in decreasing risks associated with gestational diabetes such as premature birth, immediate infant health problems, miscarriage or stillbirth.
If you have diabetes take control and monitor your treatment to ensure you are safe from complications…
Many complications associated with diabetes include kidney disease, eye disease, cardiovascular disease and diabetic ketoacidosis (a life-threatening condition that can develop in insulin dependent diabetics). Therefore, it is important to control and monitor the condition.
There are a few simple routine tests that can be carried out in conjunction with diabetes testing to test other bodily functions that may be affected by diabetes including: Microalbumin to ensure normal kidney function and Albumin to ensure normal liver function. Other speciality tests which can be requested include:
- Cystatin C is a sensitive marker of kidney function used for the detection of early renal dysfunction in diabetic patients. It is important to note that creatinine is the routine test for renal dysfunction, however it has a blind range which means it is unable to detect elevated creatinine levels found in stage 2 and halfway through stage 3 renal dysfunction. As a result of this, 50% of kidney function can be lost before elevated creatinine levels are detectable. The cystatin C test is a more sensitive marker and can detect early stages of renal dysfunction, allowing treatment to begin before it is too late
- Beta-2 Microglobulin is used when kidney damage has occurred to distinguish between the two most commonly affected sites, glomeruli and renal tubules
- D-3-Hydroxybutyrate is used in the identification of diabetic ketoacidosis, a serious complication of diabetes which occurs when blood sugar levels are consistently high and insulin levels are severely low. Immediate diagnosis is vital as the condition can lead to coma or death if not treated immediately. Symptoms include nausea, vomiting and abdominal pain
- Non-Esterified Fatty Acids (NEFA) is linked to an increased risk of developing diabetes. The measurement of NEFA is important in cases where insulin deficiency results in the metabolism of fat. An increase in NEFA concentration has also been associated with adiposity (high level of body fat), malignant disease (progressive disease) and other metabolic syndromes such as high blood pressure and abdominal obesity
Diabetes represents one of the biggest challenges for healthcare today…
The number of people both at risk of developing diabetes, as well as living with the disease, continues to increase across the world. Early diagnosis and monitoring of type 1 and type 2 diabetes is crucial to ensure associated complications do not occur. Additionally, the diagnosis and monitoring of gestational diabetes is vital to the health of mother and baby. Complications of diabetes include diabetic ketoacidosis, eye disease, cardiovascular disease, kidney disease and neuropathy (sensory, autonomic and motor).
Randox offer a few simple diabetes reagents to aid in the diagnosis and monitoring of diabetes and its associated complications. Carrying out such tests increases the chances of early diagnosis of diabetes and its associated diseases, and will assist in efforts to minimise the effects of diabetes to the healthcare industry.
You can help support efforts to minimise the effects of diabetes by asking your laboratory for these simple tests:
Routine tests include:
- Glucose, HbA1c and fructosamine for the diagnosis and monitoring of diabetes. Fructosamine is an alternative option to HbA1c and offers a much earlier indicator of diabetic control. Providing information on a person’s average blood glucose levels over a 2-3-week period. Fructosamine is useful in evaluating the effectiveness of medication changes and to monitor the treatment of gestational diabetes
- Routine tests are used in the monitoring of associated complications such as microalbumin to ensure normal kidney function and albumin to ensure normal liver function
Speciality tests for the monitoring of associated complications include:
- Cystatin C is a more sensitive marker of kidney function than creatinine. as routine creatinine has a blind range which means it is unable to detect elevated creatinine levels found in stage 2 and halfway through stage 3 of renal dysfunction. As a result, your patient could suffer the loss of 50% kidney function before elevated creatinine levels are detected. Using the cystatin C test enables early detection of renal dysfunction, allowing treatment to begin before it is too late
- Beta-2 Microglobulin is used to distinguish if kidney damage has occurred in the glomeruli or renal tubules (the two most commonly affected sites)
- D-3-Hydroxybutyrate to identify diabetic ketoacidosis (vital for quick diagnosis as this condition can lead to coma or death if not treated immediately)
- Non-Esterified Fatty Acids (NEFA) to assess diabetic patients risk of developing adiposity (high level of body fat), malignant disease (progressive disease) and other metabolic syndromes such as high blood pressure and abdominal obesity (NEFA test is important in cases where insulin deficiency results in the metabolism of fat)
Related biomarkers including:
- Adiponectin is a protein responsible for regulating the metabolism of lipids and glucose and influences the body’s response to insulin. Low levels of adiponectin are correlated with increased CRP (increased inflammation), higher levels of triglycerides and insulin resistance. Additionally, adiponectin is used to assess the level of visceral fat carried on the abdominal area around the organs. Visceral fat contributes to the risk of diabetes, heart disease, hypertension, stroke and some cancers. It is important to note that high visceral fat levels can occur even in those with a ‘normal’ BMI
If you would like more information or require informative materials for your laboratory please contact us, or alternatively download our diabetes brochure.
Randox diabetes reagents cover the full spectrum of laboratory testing requirements from risk assessment, to disease diagnosis and monitoring of associated complications. Our routine tests within the diabetes reagents panel are suitable for the diagnosis and monitoring of diabetes. The Randox diabetes reagents include: Glucose, HbA1c and Fructosamine. To ensure effective complications monitoring we have a range of routine tests including Microalbumin and Albumin, in addition to our range of specialised tests including: Beta-2 Microglobulin, D-3 Hydroxybutyrate, NEFA and Cystatin C. Cystatin C is a more sensitive indicator of renal dysfunction than routine creatinine due to the creatinine blind range. Also, the elevated creatinine levels found in stage 2 and halfway through stage 3 renal dysfunction cannot be detected. Therefore, patients can suffer from 50% of kidney dysfunction before elevated levels are detected. Using the Cystatin C test enables more accurate patient results, and allows time for treatment to begin before it is too late.
Adiponectin is also available within the Randox diabetes reagents panel which is a related biomarker used to assess the level of abdominal visceral fat which has been found to correlate with increased risk of a number of diseases. Offering the Adiponectin test will expand your portfolio of unique diabetes reagents and ensure a competitive edge in the marketplace.
Randox reagents have various benefits including:
- High quality for accurate results
- A range of methods, kits and ranges for enhanced suitability of all labs
- A range of liquid and lyophilised formats for convenience
- High stability to ensure cost effectiveness for even small throughput labs
- Controls and calibrators available
- Applications available for a wide range of clinical chemistry analysers
To order your diabetes test kits visit our online store or contact firstname.lastname@example.org to get in touch with your local sales representative. Alternatively, contact us to request a kit insert or refer to our individual product pages for further information.
Earlier this year the World Obesity Federation made the stark statement that: “The early diagnosis and treatment of childhood obesity could be considered similar to vaccination.”
Essentially, they want to see this condition treated in the same way as chicken pox, measles and mumps: tackled – in the hope of eradication – by a strategic approach founded on proactive policies and early prevention.
Obesity in children and adolescents has risen tenfold in the last 40 years, according to a recent study by The Lancet. In Britain, one in ten young people aged between 5 and 19 is obese. Worryingly, the prevalence of obesity is actually higher in younger children than older ones.
The WHO first called for obesity to be understood as a disease in 1948, but back then it wasn’t even considered a risk factor for cardiovascular disease. In 1997 the WHO held a special conference on obesity and stated that: “the global epidemic projections for the next decade are so serious that public health action is urgently required.”
Then it was alarmed that the prevalence of men with a BMI greater than 30 was 15% and 16.5% in women. To think that it has now risen dramatically to 67% for men and 57% for women, highlights just how serious a problem obesity poses to society.
The calls for more countries to officially recognise it as a disease is based on the position that obesity meets the definition of a chronic, relapsing, progressive disease that causes organ damage.
Women and men who are obese are 12.5 and 5.2 times (respectively) more likely to develop diabetes than people who are a healthy weight. 90% of people with Type 2 diabetes are obese.
People with diabetes are then at a greater risk of a range of chronic health conditions including cardiovascular disease, blindness, amputation, kidney disease and depression than people without diabetes. Diabetes leads to a two-fold excess risk for cardiovascular disease, and diabetic retinopathy is the leading cause of preventable sight loss among people of working age in England and Wales. About one in twenty people have diabetes, yet people with diabetes account for one quarter to one third of hospital admissions for cardiovascular disease.
According to Government figures released this year, people who have Type 2 diabetes are 28.4% more likely to die early than their peers.
Getting in front of this wave of diabetes will not only bring down the numbers of people affected but also see a positive impact on the numbers of obese people. As with all conditions – the earlier they are identified, the better. To do this, new methods of diagnosis are being developed.
A radical new test for a protein found in our blood called adiponectin can identify pre-diabetes. This is a game-changing diagnostic tool that empowers people with the knowledge that they are at risk, but may be able to avoid it through relatively simple lifestyle changes.
The adiponectin test is available from Randox – both for clinical use and also through our Randox Health clinics. We have developed the most comprehensive health checks available on the market. These are so sensitive that in a range of conditions including diabetes we are able to identify signs of pre-illness. This enables clients to make often simple changes to stay healthy.
We know that prevention works. The NHS carried out a study in 2016 which revealed an average 26% reduction in new cases of Type 2 diabetes in those participating in a diabetes prevention programme, compared with usual care.
To find out more, click here.
For further information please email: email@example.com
Randox Reagents are supporting World Health Day on April 7th 2016 this year!
The focus of this year’s World Health Day is on the fight against diabetes. It is essential to increase the awareness of this as a growing epidemic, let people know that diabetes is preventable and to help manage the effects of the illness in those already living with it.
What is diabetes?
Diabetes is a disease that occurs whenever the pancreas doesn’t produce enough insulin to properly regulate blood sugar levels. There are three main types of diabetes: type 1, type 2 and gestational.
Type 1 – People with this form of diabetes are unable to produce their own insulin and therefore must inject themselves with insulin.
Type 2 – This is the most common form of diabetes which occurs whenever a person can produce their own insulin but must put measures in place to control it. Type 2 diabetes accounts for 90% of diabetes cases worldwide.
Gestational – This form of diabetes affects women during pregnancy, when they develop high levels of glucose which insulin cannot bring under control.
The World Health Organisation (WHO) stated that in 2008, 347 million people had diabetes worldwide and in 2012, diabetes was the direct cause 1.5 million deaths.
Randox offer a range of high quality diabetes related diagnostic tests
It is crucial to raise awareness of diabetes to encourage people to get tested early, enabling them to put measures in place to avoid developing the illness, as well as ensuring complications do not occur. Randox are continuously developing the best quality diabetes-related diagnostic tests.
For diagnosis and monitoring
We offer tests for the diagnosis and monitoring of diabetes. These are Glucose, HbA1c and Fructosamine.
Diabetes can cause a number of complications such as chronic kidney disease, cardiovascular disease and even blindness. We offer a number of high quality tests which aid in monitoring these complications such as Albumin, Beta-2 Microglobulin, Cystatin C, D-3-Hydroxybutyrate, Microalbumin and Non-Esterified Fatty Acids (NEFA).
A related biomarker is Adiponectin, which can measure a patient’s visceral fat levels, the fat around the waist surrounding the internal organs. This can indicate heart disease risk, as well as insulin resistance.
With this broad diabetes testing panel, we will continue to support the aim to beat diabetes with World Health Day.
For more information on our diabetes tests view our diabetes page.